Pune Media

NCCN visits Vietnam in continued cancer care collaboration

The National Cancer Hospital (K Hospital) in Hanoi is hosting the ‘Best of ASCO 2024’ event. Credit: Chau Doan / Getty.

Leaders from the National Comprehensive Cancer Network (NCCN) alliance of US cancer centres are in Vietnam today (1 November) as part of a continuing collaboration to improve cancer care standards throughout the country.

The partnership with the Vietnam National Cancer Hospital and the Vietnam Cancer Association is focused on developing a version of the NCCN Harmonized Guidelines – a framework for improving and standardising cancer care – for use in Vietnam.

As part of the visit, NCCN chief executive Crystal S Denlinger will be presenting on the development and implementation of NCCN resources in Vietnam and worldwide at the ‘Best of ASCO 2024: Multimodality Treatment of Cancer and Hospital Management in the Digital Era’ event, hosted by Vietnam National Cancer Hospital (K Hospital).

Denlinger explained: “By tailoring the NCCN Guidelines to fit local needs, we can make significant strides in improving patient outcomes and ensuring that all people facing cancer in Vietnam receive the highest quality of care.”

A particular issue in the Vietnamese healthcare system is chronic overcrowding in urban hospitals. In January, the US International Trade Administration (ITA) reported that hospitals in Hanoi and Ho Chi Minh City were receiving up to 60% of the country’s patients and operating at a 200% capacity.

Other stumbling blocks to providing effective oncological care in Vietnam include a shortage of qualified medical professionals, with potential new staff deterred by relatively low wages. Most public hospitals in the country also struggle with the lack of up-to-date equipment, which slows down diagnoses and limits treatment options.

Equipping Vietnamese hospitals

Hospitals rely on the state budget to upgrade facilities, but financial constraints delay progress. The Economist Intelligence Unit (EIU) reported that, in 2022, Vietnam’s healthcare expenditure was approximately $18.5bn, representing 4.6% of the country’s GDP – half of the OECD average of 9.2%. However, a growing demand for healthcare services has increased pressure, and the government has worked to encourage the importation of medical equipment where local production cannot meet demand.

In 2022, Vietnam’s medical device market was valued at $1.5bn, and the ITA forecasts a compound annual growth rate (CAGR) of 9.7% from then through 2026, with the value to reach $2.1bn. As a result of low import duties and no quota restrictions, more than 90% of the country’s medical equipment is imported.

GlobalData’s 2022 ‘Vietnam Healthcare Market‘ report said of increased demand from the country: “The medical device industry in Vietnam has emerged as one of the most promising industries for international investment as demand for medical equipment continues to rise. To support business, the local government has provided tax concessions such as corporate income tax incentives, import duty reductions, quota exemptions and land leasing fee exemptions or reductions.”

Access the most comprehensive Company Profiles
on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

View profiles in store

Company Profile – free
sample

Your download email will arrive shortly

We are confident about the
unique
quality of our Company Profiles. However, we want you to make the most
beneficial
decision for your business, so we offer a free sample that you can download by
submitting the below form

By GlobalData

Country *
UK
USA
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bonaire, Sint
Eustatius
and
Saba
Bosnia and Herzegovina

Botswana
Bouvet Island
Brazil
British Indian Ocean
Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic

Chad
Chile
China
Christmas Island
Cocos Islands
Colombia
Comoros
Congo
Democratic Republic
of
the Congo
Cook Islands
Costa Rica
Côte d”Ivoire
Croatia
Cuba
Curaçao
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern
Territories

Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island and
McDonald
Islands

Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Isle of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
North Korea
South Korea
Kuwait
Kyrgyzstan
Lao
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya

Liechtenstein
Lithuania
Luxembourg
Macao

Macedonia,
The
Former
Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands

Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint
Helena,
Ascension and Tristan da Cunha
Saint Kitts and Nevis
Saint Lucia
Saint Pierre and Miquelon

Saint Vincent and
The
Grenadines

Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South
Georgia
and The South
Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen

Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands

Tuvalu
Uganda
Ukraine
United Arab Emirates
US Minor Outlying Islands

Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
British Virgin Islands

US Virgin Islands
Wallis and Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
Kosovo

Industry *

Academia & Education
Aerospace, Defense &
Security
Agriculture
Asset Management
Automotive
Banking & Payments
Chemicals
Construction
Consumer
Foodservice
Government, trade bodies
and NGOs
Health & Fitness
Hospitals & Healthcare

HR, Staffing &
Recruitment
Insurance
Investment Banking
Legal Services
Management Consulting
Marketing & Advertising

Media & Publishing
Medical Devices
Mining
Oil & Gas
Packaging
Pharmaceuticals
Power & Utilities
Private Equity
Real Estate
Retail
Sport
Technology
Telecom
Transportation &
Logistics
Travel, Tourism &
Hospitality
Venture Capital

Tick here to opt out of curated industry news, reports, and event updates from Pharmaceutical Technology.

Submit and
download

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

GlobalData is Hospital Management’s parent company.

Cancer in Vietnam

The most common cancer in Vietnam is breast cancer, which accounted for 24,563 (13.6%) of cases in 2022. It is closely followed by liver cancer, which accounted for 24,502 cases (also 13.6%), and lung cancer, which comprised 24,426 (13.5%).

The first set of NCCN Harmonised Guidelines for Vietnam is already available, and they focus on non-small cell lung cancer (NSCLC). Current efforts are focussed on the development of Harmonsed Guidelines for breast cancer and liver cancer, with more cancer types to follow.

K Hospital director Prof Le Van Quang commented: “These guidelines represent a significant resource for ensuring that cancer care in Vietnam is aligned with global best practices while also reflecting the realities of our local healthcare settings.”

The NCCN Harmonized Guidelines will eventually span the ten most common cancer types in Vietnam. According to 2022 data from the Global Cancer Observatory, the ten most common cancers in the country were breast, colorectum, liver, lung, stomach, thyroid, prostate, leukaemia, nasopharynx and corpus uteri.

Email newsletter icon



Images are for reference only.Images and contents gathered automatic from google or 3rd party sources.All rights on the images and contents are with their legal original owners.

Aggregated From –

Comments are closed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More